5,447 Shares in Danaher Corporation $DHR Acquired by Tred Avon Family Wealth LLC

Tred Avon Family Wealth LLC bought a new position in shares of Danaher Corporation (NYSE:DHR) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 5,447 shares of the conglomerate’s stock, valued at approximately $1,080,000.

A number of other large investors also recently modified their holdings of DHR. WFA of San Diego LLC bought a new stake in Danaher during the 2nd quarter worth $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher during the second quarter worth about $27,000. TruNorth Capital Management LLC acquired a new position in shares of Danaher in the third quarter valued at approximately $28,000. Red Tortoise LLC boosted its position in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares during the period. Finally, Tripletail Wealth Management LLC bought a new stake in Danaher during the 3rd quarter worth approximately $31,000. 79.05% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Teri List sold 3,298 shares of the stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This represents a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the sale, the senior vice president directly owned 2,625 shares in the company, valued at approximately $552,352.50. This represents a 66.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,248 shares of company stock valued at $6,609,663 in the last ninety days. 11.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms recently weighed in on DHR. Cowen restated a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. Morgan Stanley initiated coverage on Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price objective for the company. Redburn Partners set a $220.00 target price on shares of Danaher in a research note on Wednesday, October 8th. HSBC lifted their price objective on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Finally, Guggenheim lifted their target price on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 2nd. Twenty-one investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $252.83.

Danaher Trading Down 1.6%

DHR opened at $236.05 on Friday. The firm has a market capitalization of $166.73 billion, a PE ratio of 48.67, a P/E/G ratio of 4.20 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23. The company’s 50-day moving average is $228.31 and its 200 day moving average is $211.93.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the business posted $1.71 earnings per share. The company’s quarterly revenue was up 4.4% compared to the same quarter last year. As a group, research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $1.28 annualized dividend and a yield of 0.5%. Danaher’s payout ratio is currently 26.39%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.